Morning Overview on MSN
A stem cell model of the human intestine may transform how IBD treatments are discovered — researchers already identified a compound found in black licorice
For the roughly 3 million Americans living with inflammatory bowel disease, the current treatment options tell a frustrating ...
A new study published in Stem Cell Reports demonstrates how a human stem cell-derived model of the intestine can be used to identify potential therapies for inflammatory bowel disease (IBD), ...
There's one main way to treat inflammatory bowel disease (IBD): Control inflammation by whipping the immune system into shape, a process that can go haywire or fail to work. But what if the body could ...
Allogeneic HSCT achieved 92% sustained, medication-free remission and 100% survival in children with monogenic IBD, highlighting its potential as a transformative treatment. Monogenic IBD, ...
Representative immunofluorescence images showing the intestinal epithelium of a murine colitis model treated with either PBS or glycyrrhizin, adapted from Figure 2F. Cleaved Caspace-3 (red), EpCAM ...
Despite an expanding therapeutic armamentarium, remission rates in inflammatory bowel disease (IBD) appear to plateau at 30–50% after 1 year of treatment, leading to the concept of a therapeutic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results